Caribou Biosciences (CRBU) Receivables - Net (2020 - 2025)
Caribou Biosciences (CRBU) has disclosed Receivables - Net for 6 consecutive years, with $242000.0 as the latest value for Q3 2025.
- On a quarterly basis, Receivables - Net rose 31.52% to $242000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $242000.0, a 31.52% increase, with the full-year FY2024 number at $265000.0, up 79.05% from a year prior.
- Receivables - Net was $242000.0 for Q3 2025 at Caribou Biosciences, up from $71000.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $1.5 million in Q1 2023 to a low of $2000.0 in Q2 2021.
- A 5-year average of $488444.4 and a median of $319500.0 in 2022 define the central range for Receivables - Net.
- Peak YoY movement for Receivables - Net: surged 26100.0% in 2022, then plummeted 90.4% in 2025.
- Caribou Biosciences' Receivables - Net stood at $1.2 million in 2021, then tumbled by 82.48% to $202000.0 in 2022, then dropped by 26.73% to $148000.0 in 2023, then skyrocketed by 79.05% to $265000.0 in 2024, then dropped by 8.68% to $242000.0 in 2025.
- Per Business Quant, the three most recent readings for CRBU's Receivables - Net are $242000.0 (Q3 2025), $71000.0 (Q2 2025), and $88000.0 (Q1 2025).